This record was last updated October 1, 2024 (before its estimated November 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-14; most recent amendment 2024-09-27.
Status change: Not Yet Recruiting → Recruiting2024-07-17